Growing biomedical research for drug development and diagnostics of cancer is expected to build a favorable atmosphere for the growth of the multiphoton microscopy market in the near future. Moreover, various clinical development programs in several countries are focused at increasing cancer screening programs with the help of governments. This is leading to the early screening and diagnosis of cancer patients. Multiphoton microscopy is now also being used for imaging in clinical oncology diagnostic tests. Growing prevalence of cancer across the world is expected to fuel demand for multiphoton microscopy across geographies.
Currently, players in the multiphoton microscopy space are consistently making changes in their product categories and technologies in order to enhance device capabilities. For instance, in December 2020, ZEISS introduced ZEISS Lattice lightsheet 7; this product is tailored to observe cellular processes within cells and small organisms in 3D over extended time periods, all at a subcellular resolution with minimum light dosage.
Request a Report Sample to Gain Valuable Insights >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=3405
The global multiphoton microscopy market was valued at around US$ 150 Mn in 2019, and is projected to expand at a CAGR of close to 5% through 2031.
Key Takeaways from Multiphoton Microscopy Market Study
Two-photon microscopy accounted for 94.2% market share in 2020.
Deep tissue imaging is the most lucrative segment and holds nearly 18% of the market share.
North America and Europe collectively hold over half of the global multiphoton microscopy market share, owing to technological advancements and increasing mergers and collaborations in these regions.
Hospitals & clinics account for over 5% value share, since they serve as the primary centers for disease diagnosis and treatment.
The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Medical device manufacturers have been severely impacted, with companies reporting significant drop in revenue due to the cancellation of diagnostic procedures.
“Rising adoption of e-Commerce and increasing technological advancements are factors anticipated to aid growth of the global multiphoton microscopy market over the coming years,” says a Fact.MR analyst.
Request Methodology & Get a Glimpse of Our Expertise >>> https://www.factmr.com/connectus/sample?flag=RM&rep_id=3405
Addition of Innovative Products in Portfolio through Partnerships
To retain their positions in the market, prominent medical device manufacturers are identifying potential assets from smaller firms, which typically have limited resources to see projects through to the market. Through licensing deals and partnerships, companies are acquiring new products, while continuing to pursue their own in-house development strategies.
For instance, in September, 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology, and cell therapy. This acquisition enhances Bruker’s offerings in targeted multi-omics and fluorescence-based imaging techniques.
Looking for more information?
The research study on the multiphoton microscopy market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape over 2015 – 2019, and includes detailed assessment of key parameters that are anticipated to exert influence during 2020 – 2030. Market statistics have been presented based on product (two-photon microscopy and three-photon microscopy), application (skin imaging, neuroscience, oncology, immunology, embryology, deep tissue imaging, functional and molecular imaging, intravital imaging, cell culture, virology, and others), and end user (hospitals & clinics, clinical & diagnostic laboratories, and academic & research institutes), across seven regions – North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.
Interested to Procure The Data? Inquire here at >>> https://www.factmr.com/connectus/sample?flag=AE&rep_id=3405
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
